Thanksgiving is coming, which means it’s time for our favorite podcast of the year: What are You Thankful for in Workers’ Comp? This year, we invited three experts who share very different reasons why they are grateful for comp: Heart of Case Management Award winner Charlene Ramsey, RN, BSN, CCM; Helen Froehlich, vice president of case management; and Donna Bradshaw, vice president of IME Services. We hope their responses lead you to contemplate on your own unique role in workers’ comp and how YOU make a difference in the lives of others.
More stories
What's the difference between a drug allergy and a side effect?
Drug allergies and side effects present differences that are often misunderstood. They are commonly discussed in overlapping terms that can understate the importance in how each should be managed (Eg. “I think I’m allergic to Aspirin, it upsets my stomach”).
Disaster Recovery and Work Comp
In just the past few years, natural disasters have generated startling headlines and produced enormous challenges for many, including for workers’ compensation systems.
Mitchell’s Tina Greene Elected to Cooperative Exchange, The National Clearinghouse Association Board
The Cooperative Exchange, The National Clearinghouse Association promotes and advances electronic data exchange in the healthcare industry.
My Way, Right Now
How quickly do you get frustrated with slow service? Whether you are waiting a little longer for your food to be served at a restaurant, or even waiting on that red light that took forever this morning on the way to work, our patience continues to lessen.
Chronicling the World of Workers’ Comp with Roberto Ceniceros
Last month, workers’ compensation lost one of its most talented reporters and influencers as Roberto Ceniceros announced his retirement.
Gabapentinoids in Workers’ Compensation
Nearly 20 percent of U.S. adults suffer from chronic pain. This is especially vital in the workers’ compensation world that is now asking, ‘are gabapentinoids the answer to that pain?’ Current increases in prescribing of gabapentinoids and the drugs’ less addictive qualities as compared to opioids may initially suggest so.